Venlafaxine 25 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 30
- Registration Number
- NCT00834964
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Cefdinir Capsules 300 mg, Non-fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: OMNICEF® Capsule 300 mg
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00834535
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00834197
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00834873
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Cefadroxil 500 mg Capsules Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DURICEF® capsules 500 mg
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 26
- Registration Number
- NCT00834275
- Locations
- 🇺🇸
Bioassay Laboratory, Inc., Houston, Texas, United States
🇨🇦Biovail Contract Research, Toronto, Ontario, Canada
Azithromycin 600 Mg Tablets, Fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT00834756
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Amlodipine-benazepril 10 mg-20 mg capsules
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 68
- Registration Number
- NCT00835367
- Locations
- 🇨🇦
Anapharm Inc., Montreal, Quebec, Canada
🇨🇦SFBC Anapharm, Sainte-Foy, Quebec, Canada
15 mg Mirtazapine Orally Disintegrating Tablets, Fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00835575
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Granisetron 1 mg Tablets, Non-fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 80
- Registration Number
- NCT00834522
- Locations
- 🇨🇦
Pharma Medica Research Inc, Toronto, Ontario, Canada
Leflunomide 20 mg Tablets, Non-Fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 37
- Registration Number
- NCT00834405
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States